| Factor Information | |
|---|---|
| Data ID | 668 |
| Factor | presence of prosthetic material with recurrent IE |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | recurrent IE rate in patients with presence of prosthetic material. |
| p Value | 0.017 |
| OR | 5.9 |
| Conclusion | Recurrent IE was significantly more likely in patients with IE related to the presence of prosthetic material. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 475 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
| Reference | |
|---|---|
| PMID | 29121720 |
| Year | 2017 |
| Title | Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Australia,Sydney | |
| Method | Univariate and multivariate analyses | |
| Race | Australian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | prosthetic(Treatment) | control(Control) |
| Number | 35 | 74 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
